Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 39.02
-0.64 (-1.61%)
At close: Feb 12, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 21.38 billion as of February 13, 2026. Its market cap has decreased by -38.65% in one year.
Market Cap
21.38B
Enterprise Value
22.16B
Revenue
17.87B
Ranking
n/a
PE Ratio
21.58
Stock Price
39.02
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 21.38B, an increase of 146.95%. That is a compound annual growth rate of 3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 21.38B | -4.99% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 31.49B |
| Unichem Laboratories | 27.24B |
| Hikal | 26.70B |
| Bliss GVS Pharma | 22.67B |
| Novartis India | 20.50B |
| Shukra Pharmaceuticals | 18.50B |
| Amrutanjan Health Care | 18.44B |
| TTK Healthcare | 13.45B |